Response to PARP Inhibition in BARD1 -Mutated Refractory Neuroblastoma.

MLA

Cupit-Link, Margaret, et al. “Response to PARP Inhibition in BARD1 -Mutated Refractory Neuroblastoma.” The New England Journal of Medicine, vol. 391, no. 7, Aug. 2024, pp. 659–61. EBSCOhost, https://doi.org/10.1056/NEJMc2403316.

APA

Cupit-Link, M., Hagiwara, K., Nagy, M., Koo, S. C., Orr, B. A., Ruppin, E., Easton, J., Zhang, J., & Federico, S. M. (2024). Response to PARP Inhibition in BARD1 -Mutated Refractory Neuroblastoma. The New England Journal of Medicine, 391(7), 659–661. https://doi.org/10.1056/NEJMc2403316

Chicago

Cupit-Link, Margaret, Kohei Hagiwara, Matthew Nagy, Selene C Koo, Brent A Orr, Eytan Ruppin, John Easton, Jinghui Zhang, and Sara M Federico. 2024. “Response to PARP Inhibition in BARD1 -Mutated Refractory Neuroblastoma.” The New England Journal of Medicine 391 (7): 659–61. doi:10.1056/NEJMc2403316.